Skip to main content
Top
Published in: Digestive Diseases and Sciences 3/2022

01-03-2022 | Metastasis | Original Article

Proteasome Subunit Alpha Type 7 Promotes Proliferation and Metastasis of Gastric Cancer Through MAPK Signaling Pathway

Authors: Shujing Xia, Lei Ji, Lizhong Tang, Lili Zhang, Xiumei Zhang, Qi Tang, Zhenqing Feng, Lungen Lu

Published in: Digestive Diseases and Sciences | Issue 3/2022

Login to get access

Abstract

Background

Proteasome subunit alpha type 7 (PSMA7) shows a carcinogenic effect on various human malignancies, but its role and regulatory mechanism in gastric carcinoma (GC) remain unclear.

Aims

This study aimed to explore the role and mechanism of PSMA7 in GC.

Methods

In this study, PSMA7 expressions in GC cells and tissues were detected, and relationships between PSMA7 and clinicopathological features were explored. Then, PSMA7 levels in human GC cells were intervened, and changes in cell biological behavior were observed in vitro and vivo. Key proteins and downstream factors of MAPK signaling pathway were detected after PSMA7 intervention.

Results

PSMA7 was upregulated in GC tissues and cell lines. PSMA7 overexpression was significantly associated with poor pTNM, cTNM stage, and high HP infection. PSMA7 can promote proliferation, invasion, and metastasis of GC cells in vitro and vivo. Furthermore, PSMA7 expression affected the phosphorylation level of JNK, P38, ERK and the expressions of their downstream factors Ap-1, c-myc, P53.

Conclusion

PSMA7 can promote GC proliferation, invasion, and metastasis through MAPK signaling pathway in GC cells.
Literature
1.
go back to reference Choi RS, Lai WYX, Lee LTC, Wong WLC, Pei XM, Tsang HF, Leung JJ, Cho WCS, Chu MKM, Wong EYL. Current and future molecular diagnostics of gastric cancer. Expert Revi Mol Diagn 2019;19:863–874CrossRef Choi RS, Lai WYX, Lee LTC, Wong WLC, Pei XM, Tsang HF, Leung JJ, Cho WCS, Chu MKM, Wong EYL. Current and future molecular diagnostics of gastric cancer. Expert Revi Mol Diagn 2019;19:863–874CrossRef
2.
go back to reference Venerito M, Vasapolli R, Rokkas T, Malfertheiner P. Gastric cancer: epidemiology, prevention, and therapy. Helicobacter 2018;23:e12518CrossRef Venerito M, Vasapolli R, Rokkas T, Malfertheiner P. Gastric cancer: epidemiology, prevention, and therapy. Helicobacter 2018;23:e12518CrossRef
3.
go back to reference Cao W, Wei W, Zhan Z, Xie D, Xie Y, Xiao Q. Regulation of drug resistance and metastasis of gastric cancer cells via the microRNA647-ANK2 axis. Int J Mol Med 2018;41:1958–1966PubMedPubMedCentral Cao W, Wei W, Zhan Z, Xie D, Xie Y, Xiao Q. Regulation of drug resistance and metastasis of gastric cancer cells via the microRNA647-ANK2 axis. Int J Mol Med 2018;41:1958–1966PubMedPubMedCentral
4.
go back to reference Bando E, Makuuchi R, Irino T, Tanizawa Y, Kawamura T, Terashima M. Validation of the prognostic impact of the new tumor-node-metastasis clinical staging in patients with gastric cancer. Gastric Cancer 2018;22:123–129CrossRef Bando E, Makuuchi R, Irino T, Tanizawa Y, Kawamura T, Terashima M. Validation of the prognostic impact of the new tumor-node-metastasis clinical staging in patients with gastric cancer. Gastric Cancer 2018;22:123–129CrossRef
5.
go back to reference Zhang RR, Zhou WB, Pan ZG, Pathology DO. Study on the mechanism of RNA interference Rac1 to inhibit the proliferation and promote apoptosis of human gastric cancer cell line. J Clin Exp Med 2017;16:1279–1282 Zhang RR, Zhou WB, Pan ZG, Pathology DO. Study on the mechanism of RNA interference Rac1 to inhibit the proliferation and promote apoptosis of human gastric cancer cell line. J Clin Exp Med 2017;16:1279–1282
6.
go back to reference Cheng Z, Zhang D, Gong B, Wang P, Liu F. CD163 as a novel target gene of STAT3 is a potential therapeutic target for gastric cancer. Oncotarget 2017;8:87244–87262CrossRef Cheng Z, Zhang D, Gong B, Wang P, Liu F. CD163 as a novel target gene of STAT3 is a potential therapeutic target for gastric cancer. Oncotarget 2017;8:87244–87262CrossRef
7.
go back to reference Ren CC, Yang L, Liu L, Chen YN, Cheng GM, Zhang XA, Liu H. Effects of shRNA-mediated silencing of PSMA7 on cell proliferation and vascular endothelial growth factor expression via the ubiquitin-proteasome pathway in cervical cancer. J Cell Physiol 2018;234:5851–5862CrossRef Ren CC, Yang L, Liu L, Chen YN, Cheng GM, Zhang XA, Liu H. Effects of shRNA-mediated silencing of PSMA7 on cell proliferation and vascular endothelial growth factor expression via the ubiquitin-proteasome pathway in cervical cancer. J Cell Physiol 2018;234:5851–5862CrossRef
8.
go back to reference Hu XT, Chen W, Wang D, Shi QL, Zhang FB, Liao YQ, Jin M, He C. The proteasome subunit PSMA7 located on the 20q13 amplicon is overexpressed and associated with liver metastasis in colorectal cancer. Oncol Rep. 2008;19:441–446PubMed Hu XT, Chen W, Wang D, Shi QL, Zhang FB, Liao YQ, Jin M, He C. The proteasome subunit PSMA7 located on the 20q13 amplicon is overexpressed and associated with liver metastasis in colorectal cancer. Oncol Rep. 2008;19:441–446PubMed
9.
go back to reference Tan JY, Huang X, Luo YL. PSMA7 inhibits the tumorigenicity of A549 human lung adenocarcinoma cells. Mol Cell Bioch. 2012;366:131–137CrossRef Tan JY, Huang X, Luo YL. PSMA7 inhibits the tumorigenicity of A549 human lung adenocarcinoma cells. Mol Cell Bioch. 2012;366:131–137CrossRef
10.
go back to reference Honma K, Takemasa I, Matoba R, Yamamoto Y, Takeshita F, Mori M, Monden M, Matsubara K, Ochiya T. Screening of potential molecular targets for colorectal cancer therapy. Int J Gen Med. 2009;2:243–257PubMedPubMedCentral Honma K, Takemasa I, Matoba R, Yamamoto Y, Takeshita F, Mori M, Monden M, Matsubara K, Ochiya T. Screening of potential molecular targets for colorectal cancer therapy. Int J Gen Med. 2009;2:243–257PubMedPubMedCentral
11.
go back to reference Krüger M, Beger C, Welch PJ, Barber JR, Manns MP, Wongstaal F. Involvement of proteasome α-subunit PSMA7 in hepatitis C virus internal ribosome entry site-mediated translation. J Hepatol. 2001;34:8357–8364 Krüger M, Beger C, Welch PJ, Barber JR, Manns MP, Wongstaal F. Involvement of proteasome α-subunit PSMA7 in hepatitis C virus internal ribosome entry site-mediated translation. J Hepatol. 2001;34:8357–8364
12.
go back to reference Xia S, Tang Q, Wang X, Zhang L, Jia L, Wu D, Xu P, Zhang X, Tang G, Yang T, Feng Z, Lu L. Overexpression of PSMA7 predicts poor prognosis in patients with gastric cancer. Oncol Let. 2019;18:5341–5349 Xia S, Tang Q, Wang X, Zhang L, Jia L, Wu D, Xu P, Zhang X, Tang G, Yang T, Feng Z, Lu L. Overexpression of PSMA7 predicts poor prognosis in patients with gastric cancer. Oncol Let. 2019;18:5341–5349
13.
go back to reference Zheng Z, Dong XJ. Clinical value of serum trophoblast cell surface protein 2 (TROP2) antibody in non-small cell lung cancer patients. Bio Bioch Ind Exp Re Sus Che. 2016;21:739–742 Zheng Z, Dong XJ. Clinical value of serum trophoblast cell surface protein 2 (TROP2) antibody in non-small cell lung cancer patients. Bio Bioch Ind Exp Re Sus Che. 2016;21:739–742
14.
go back to reference Hu XT, Chen W, Wang D, Shi QL, Zhang FB, Liao YQ, Jin M, He C. High expression of proteasome subunit PSMA7 in colorectal cancer is significantly correlated with liver metastasis. Chin J Oncol 2008;30:515 Hu XT, Chen W, Wang D, Shi QL, Zhang FB, Liao YQ, Jin M, He C. High expression of proteasome subunit PSMA7 in colorectal cancer is significantly correlated with liver metastasis. Chin J Oncol 2008;30:515
15.
go back to reference Cai CJ, Ye SJ, Zhu W, Sun LY, Wan HS, Feng ZH, Ma L, Li L. Study on invasion and metastasis-associated genes of lung cancer related with NM23-H1 gene. J Sichuan Uni Med Sci Edi 2010;41:941 Cai CJ, Ye SJ, Zhu W, Sun LY, Wan HS, Feng ZH, Ma L, Li L. Study on invasion and metastasis-associated genes of lung cancer related with NM23-H1 gene. J Sichuan Uni Med Sci Edi 2010;41:941
17.
go back to reference Sheng W, Chen Y, Tu C et al. ANGPTL2 expression in gastric cancer tissues and cells and its biological behavior. World J Gastroenterol 2016;22:10364–10370CrossRef Sheng W, Chen Y, Tu C et al. ANGPTL2 expression in gastric cancer tissues and cells and its biological behavior. World J Gastroenterol 2016;22:10364–10370CrossRef
18.
go back to reference Qin T, Fan CQ, Zhu N, Shen Y, Chen MH. Knockdown of proteasome subunit α7 with small interfering RNA inhibits cell proliferation of K562 cell line. Acta Aca Med Sin 2013;35:601–606 Qin T, Fan CQ, Zhu N, Shen Y, Chen MH. Knockdown of proteasome subunit α7 with small interfering RNA inhibits cell proliferation of K562 cell line. Acta Aca Med Sin 2013;35:601–606
19.
go back to reference Hu X, Chen W, Zhang F et al. Depletion of the proteasome subunit PSMA7 inhibits colorectal cancer cell tumorigenicity and migration. Oncol Rep 2009;22:1247–1252PubMed Hu X, Chen W, Zhang F et al. Depletion of the proteasome subunit PSMA7 inhibits colorectal cancer cell tumorigenicity and migration. Oncol Rep 2009;22:1247–1252PubMed
20.
go back to reference Tan J, Huang X, Luo Y et al. PSMA7 inhibits the tumorigenicity of A549 human lung adenocarcinoma cells. Mol Cell Biochem 2012;366:131–137CrossRef Tan J, Huang X, Luo Y et al. PSMA7 inhibits the tumorigenicity of A549 human lung adenocarcinoma cells. Mol Cell Biochem 2012;366:131–137CrossRef
21.
go back to reference Zhu T, Hu X, Wei P, Shan G. Molecular background of the regional lymph node metastasis of gastric cancer. Oncol Lett 2018;15:3409–3414PubMedPubMedCentral Zhu T, Hu X, Wei P, Shan G. Molecular background of the regional lymph node metastasis of gastric cancer. Oncol Lett 2018;15:3409–3414PubMedPubMedCentral
22.
go back to reference Saito H, Kihara K, Kuroda H, Matsunaga T, Tatebe S, Ikeguchi M. Surgical outcomes for gastric cancer patients with intraperitoneal free cancer cell, but no macroscopic peritoneal metastasis. J Sur Oncol 2011;104:534–537CrossRef Saito H, Kihara K, Kuroda H, Matsunaga T, Tatebe S, Ikeguchi M. Surgical outcomes for gastric cancer patients with intraperitoneal free cancer cell, but no macroscopic peritoneal metastasis. J Sur Oncol 2011;104:534–537CrossRef
23.
go back to reference Evans MK, Brown MC, Geradts J, Bao X, Robinson TJ, Jolly MK, Vermeulen PB, Palmer GM, Gromeier M, Levine H. XIAP regulation by MNK links MAPK and NFκB signaling to determine an aggressive breast cancer phenotype. Cancer Res 2018;78:1726–1738CrossRef Evans MK, Brown MC, Geradts J, Bao X, Robinson TJ, Jolly MK, Vermeulen PB, Palmer GM, Gromeier M, Levine H. XIAP regulation by MNK links MAPK and NFκB signaling to determine an aggressive breast cancer phenotype. Cancer Res 2018;78:1726–1738CrossRef
24.
go back to reference Jiang K, Lu Q, Li Q, Ji Y, Chen W, Xue X. Astragaloside IV inhibits breast cancer cell invasion by suppressing Vav3 mediated Rac1/MAPK signaling. Int Immunopharmacol 2017;42:195–202CrossRef Jiang K, Lu Q, Li Q, Ji Y, Chen W, Xue X. Astragaloside IV inhibits breast cancer cell invasion by suppressing Vav3 mediated Rac1/MAPK signaling. Int Immunopharmacol 2017;42:195–202CrossRef
25.
go back to reference Sun Q, Liang Y, Zhang T, Wang K, Yang X. ER-α36 mediates estrogen-stimulated MAPK/ERK activation and regulates migration, invasion, proliferation in cervical cancer cells. Biochem Biol Res Commun 2017;487:625–632CrossRef Sun Q, Liang Y, Zhang T, Wang K, Yang X. ER-α36 mediates estrogen-stimulated MAPK/ERK activation and regulates migration, invasion, proliferation in cervical cancer cells. Biochem Biol Res Commun 2017;487:625–632CrossRef
26.
go back to reference Lanna A, Gomes DCO, Muller-Durovic B, McDonnell T, Escors D, Gilroy DW, Lee JH, Karin M, Akbar AN. A sestrin-dependent Erk-Jnk-p38 MAPK activation complex inhibits immunity during aging. Nat Immunol 2017;18:354–363CrossRef Lanna A, Gomes DCO, Muller-Durovic B, McDonnell T, Escors D, Gilroy DW, Lee JH, Karin M, Akbar AN. A sestrin-dependent Erk-Jnk-p38 MAPK activation complex inhibits immunity during aging. Nat Immunol 2017;18:354–363CrossRef
27.
go back to reference Cicenas J, Zalyte E, Rimkus A, Dapkus D, Noreika R, Urbonavicius S. JNK, p38, ERK, and SGK1 inhibitors in cancer. Cancers 2017;10:1CrossRef Cicenas J, Zalyte E, Rimkus A, Dapkus D, Noreika R, Urbonavicius S. JNK, p38, ERK, and SGK1 inhibitors in cancer. Cancers 2017;10:1CrossRef
28.
go back to reference Yang L, Tang Z, Zhang H, Kou W, Lu Z, Li X, Li Q, Miao Z. PSMA7 directly interacts with NOD1 and regulates its function. Cell Physiol Biochem. 2013;31:952–959CrossRef Yang L, Tang Z, Zhang H, Kou W, Lu Z, Li X, Li Q, Miao Z. PSMA7 directly interacts with NOD1 and regulates its function. Cell Physiol Biochem. 2013;31:952–959CrossRef
29.
go back to reference Wang Z, Liu M, Nie X, Zhang Y, Chen Y, Zhu L, Chen X, Chen L, Chen H, Zhang J. NOD1 and NOD2 control the invasiveness of trophoblast cells via the MAPK/p38 signaling pathway in human first-trimester pregnancy. Placenta 2015;36:652–660CrossRef Wang Z, Liu M, Nie X, Zhang Y, Chen Y, Zhu L, Chen X, Chen L, Chen H, Zhang J. NOD1 and NOD2 control the invasiveness of trophoblast cells via the MAPK/p38 signaling pathway in human first-trimester pregnancy. Placenta 2015;36:652–660CrossRef
30.
go back to reference Sankpal NV, Mayfield J, Willman M, Fleming TP, Gillanders WE. Activator protein 1 (AP-1) contributes to EpCAM-dependent breast cancer invasion. Breast Cancer Res 2011;13:1–13CrossRef Sankpal NV, Mayfield J, Willman M, Fleming TP, Gillanders WE. Activator protein 1 (AP-1) contributes to EpCAM-dependent breast cancer invasion. Breast Cancer Res 2011;13:1–13CrossRef
31.
go back to reference He X, Tan X, Wang X, Jin H, Liu L, Ma L, Yu H, Fan Z. C-Myc-activated long noncoding RNA CCAT1 promotes colon cancer cell proliferation and invasion. Tumor Biol 2014;35:12181–12188CrossRef He X, Tan X, Wang X, Jin H, Liu L, Ma L, Yu H, Fan Z. C-Myc-activated long noncoding RNA CCAT1 promotes colon cancer cell proliferation and invasion. Tumor Biol 2014;35:12181–12188CrossRef
32.
go back to reference Ramadoss S, Guo G, Wang CY. Lysine demethylase KDM3A regulates breast cancer cell invasion and apoptosis by targeting histone and the non-histone protein p53. Oncogene 2017;36:47–59CrossRef Ramadoss S, Guo G, Wang CY. Lysine demethylase KDM3A regulates breast cancer cell invasion and apoptosis by targeting histone and the non-histone protein p53. Oncogene 2017;36:47–59CrossRef
Metadata
Title
Proteasome Subunit Alpha Type 7 Promotes Proliferation and Metastasis of Gastric Cancer Through MAPK Signaling Pathway
Authors
Shujing Xia
Lei Ji
Lizhong Tang
Lili Zhang
Xiumei Zhang
Qi Tang
Zhenqing Feng
Lungen Lu
Publication date
01-03-2022
Publisher
Springer US
Published in
Digestive Diseases and Sciences / Issue 3/2022
Print ISSN: 0163-2116
Electronic ISSN: 1573-2568
DOI
https://doi.org/10.1007/s10620-021-06903-9

Other articles of this Issue 3/2022

Digestive Diseases and Sciences 3/2022 Go to the issue
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.